Featured Content
CVS Health unveiled its first pharmacy-focused CVS Pharmacy in the Boston area Oct. 7. The site is meant to expand…
More in Pharmacy
The FDA has approved AbbVie’s Juvmo (tavapadon) tablets for adults with Parkinson’s disease, making it the first and only selective D1/D5 receptor agonist approved for adults with the condition. The once-daily treatment can be taken with or without oral levodopa…
Pharmacist pay varies by more than $35,000 depending on practice setting, according to a June Drug Channels Institute analysis of May 2025 Bureau of Labor Statistics data. The figures reflect average base pay and exclude bonuses and employer benefit costs.…
Pharmacist employment continues to shift away from retail and toward hospitals and other clinical settings, according to a June analysis from Drug Channels Institute of May 2025 Bureau of Labor Statistics data. Here are four things to know:
Plenful, the leading AI automation platform for pharmacy teams, is ready with Rebate Intelligence. The solution gives covered entities an automated way to submit and reconcile rebates under the Health Resources and Services Administration’s (HRSA) revised 340B Rebate Model Pilot…
Most patients with advanced pancreatic cancer treated with daraxonrasib will see the drug lose its effect, and researchers are starting to identify why, according to a Sept. 30 report in The New York Times. The FDA approved Revolution Medicines’ daraxonrasib…
Louisville, Ky.-based Baptist Health nearly doubled the share of discharged patients leaving with prescriptions in hand. Then it made enrollment automatic. The system flipped its Meds to Beds program from opt-in to opt-out in Epic this year after pushing capture…
The FDA has approved pirtobrutinib (Jaypirca, Eli Lilly) for adults with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma with no known 17p deletion. The Oct. 2 approval was based on BRUIN CLL-313, a trial involving 282 patients randomized…
CMS opened its Medicare Part D Claims Data 340B Repository Oct. 1 for voluntary data submissions, ahead of a proposed Jan. 1, 2027, deadline when submissions would become mandatory for 340B covered entities and their third-party administrators. Here are four…
HRSA announced Oct. 1 that it has approved 10 drugmakers to participate in a revised 340B Rebate Model Pilot Program, which will replace the traditional upfront 340B discount with a post-sale rebate structure for a limited set of drugs starting…
Becker’s asked pharmacy executives from hospitals and health systems, along with academic medical centers and universities across the U.S. to share what trends they deem dangerous. The 14 executives featured in this article are all speaking at Becker’s Healthcare 3rd…